Healy 2016.
Methods |
Study design: cluster‐randomised controlled trial Study duration: 12 months Dropout: 18% at 12 months (all participants) Location: 1 government organisation at various work sites in metropolitan and regional Victoria, Australia Recruitment: sites were identified if they were geographically separate (≥ 1 km apart) from other sites in the same organisation. At each site, a team was formed that included a working group and a line manager; the team met on a regular basis |
|
Participants |
Population: office workers working in the organisation Intervention group: 136 participants with 12 to 54 participants with baseline pain in 1 or more body regions Control group: 95 participants with 4 to 37 participants with baseline pain in 1 or more body regions Included criteria: required to work at least 0.6 full‐time equivalent; 18 to 65 years of age; ability to speak English; access to telephone, Internet, and dedicated desk at the workplace Excluded criteria: pregnant, non‐ambulatory, planned absence from work for longer than 2 weeks, planned relocation to another work site within the first 3 months of the intervention Baseline characteristics: approximately equal proportions of participants in intervention and control groups reported baseline musculoskeletal symptoms |
|
Interventions |
Intervention
Control
|
|
Outcomes |
Outcome name, measurement tool, body region
|
|
Identification | ||
Notes | Sponsorship source: Ergotron Ltd (www.ergotron.com) provided sit‐stand workstations for the present study. Ergotron had no influence on the conduct or findings of the study | |
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Random sequence generation | Unclear risk | Quote: "randomization to either the intervention or the control arms of the trial was at the level of the work site via simple cluster randomization. This was achieved by generating a randomization plan for up to 24 clusters in one block (www.randomization.com)" Judgement comment: although the overall randomisation procedure was low risk, as only a select group of participants with baseline pain were included in the review, randomisation was compromised |
Allocation concealment | Low risk | Quote: "this was achieved by generating a randomization plan for up to 24 clusters in one block (www.randomization.com) by a research staff member not involved in recruitment or data collection" |
Blinding of participants and personnel | High risk | Quote: "participants and study staff were unblinded to group allocation" |
Blinding of outcome assessment | Unclear risk | Judgement comment: in addition, for this study, musculoskeletal outcomes were a secondary outcome, so it is unclear whether the fact that participants were not blinded to the intervention would contribute to bias in self‐reporting of musculoskeletal outcomes |
Incomplete outcome data | Unclear risk | Judgement comment: for the whole cohort ‐ at 3‐month follow‐up, 7/136 in the intervention group were lost to follow‐up and 5/95 in the control group; at 12‐month follow‐up, 22/136 in the intervention group were lost to follow‐up and 20/95 in the intervention group. Attrition was greater in the control group (31%) than in the intervention group (16%). Attrition details for participants with baseline pain were not provided |
Selective reporting | Low risk | Judgement comment: outcomes reported are consistent with the clinical trial registration. However, the full list of outcomes is reported elsewhere (Healy 2017) |
Baseline imbalance | Low risk | Judgement comment: appears to be equal balance of participants with baseline pain in intervention and control groups |